NAEUN HOSPITAL
No hidden fees – just official clinic prices. Pay at the clinic for Chronic Heart Failure (CHF) treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Chronic Heart Failure (CHF) treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Chronic Heart Failure (CHF) treatment journey.
Dr. Oh Dongju, MD, PhD, is a cardiologist. He specializes in hypertension, hyperlipidemia, angina, myocardial infarction, valvular disease, dilated cardiomyopathy, and myocarditis. His work also covers atherosclerosis and arterial occlusive disease. He is skilled in echocardiography and cardiovascular imaging.
He completed a cardiology fellowship at Emory University School of Medicine. He also served as a Clinical Instructor at the Cornell University Weill Department of Medicine. He has held many leadership roles. He served as President, KSIC; Director of Publications, General Affairs, and Public Relations, KSC; Chairman, KACG; Board Member, Asan Heart Foundation; Vice President, KHA; Chairman, Division of Cardiology, KAIM; Vice President, NAMOK/KAMS; Governor, ACC Korea Chapter; and Member, the National Bioethics Committee.
Dr. Ahn Taehun is a cardiologist (MD, PhD) and Director of a Cardiovascular Center. He specializes in coronary artery disease, including angina and myocardial infarction. He also treats hypertension, heart valve disease, heart failure, and hyperlipidemia. His expertise includes interventional cardiology, echocardiography, and cardiovascular imaging. He also manages atherosclerosis, arterial occlusive disease, dilated cardiomyopathy, and myocarditis.
He has held several leadership roles. He served as Chairman of the Board of the Korean Society of Interventional Cardiology (KSIC) and President of the Korean Society of Cardiology (KSC). He was Finance Director of the KSC. He led the Korean Vascular Intervention Society (KVIS) and the Korean Cardiovascular Complications Committee (KCCC) as President. He also chaired the Organizing Committee for ENCORE SEOUL (Endovascular & Coronary Revascularization).
Dr. Byung Hee Oh is a cardiologist at Incheon Sejong Hospital. He previously served as President of the Korean Society of Cardiology. Dr. Oh specializes in heart failure, coronary artery disease, and complex arrhythmias. He held leadership roles at Seoul National University Hospital. Dr. Oh has authored hundreds of peer-reviewed publications. He treats patients at Sejong Hospital, which sees over 400,000 annual visits.
Dr. Kyung Hee Kim is the Director of the Heart Transplantation Center at Incheon Sejong Hospital. She serves on the American Heart Association’s Clinical Cardiology Membership Committee. This is a rare leadership role for a Korean cardiologist. Dr. Kim specializes in heart failure, transplant management, and mechanical circulatory support. She holds an MD and PhD from Seoul National University.
South Korea offers high-success cardiac care at institutions like Sejong Hospital, Seoul National University Hospital, and Severance Hospital. These facilities utilize multidisciplinary heart failure teams. They integrate advanced mechanical circulatory support, heart transplantation programs, and digital monitoring systems. Most centers hold KOIHA or JCI accreditation for safety.
Bookimed Expert Insight: While university hospitals in Seoul are prestigious, Sejong Hospital in Incheon manages over 400,000 patient visits annually. This massive volume ensures surgeons maintain high proficiency. Dr. Kyung-Hee Kim there even contributes to global AHA guidelines. For heart failure, this specific volume often leads to better long-term management outcomes.
Patient Consensus: Patients note it's important to choose centers that allow for continuity of care with the same cardiologist. They emphasize looking for facilities with dedicated ICU backup for complex device therapies.
South Korea offers high-success advanced heart failure treatments including heart transplantation, ventricular assist devices (VAD), and extracorporeal membrane oxygenation (ECMO). Specialized centers like Sejong Hospital provide these services under KOIHA accreditation. One-year survival rates for heart transplants in the region reach 90%.
Bookimed Expert Insight: Patient volume often signals specialized expertise in Korea. Sejong Hospital manages over 402,000 patients annually. This massive scale allows doctors like Dr. Kyung Hee Kim to develop highly refined protocols for mechanical circulatory support. Expert leadership, such as former Korean Society of Cardiology presidents, typically concentrates at these high-volume centers.
Patient Consensus: Patients note that advanced care feels like a ladder of escalation. They emphasize the importance of having a coordinated team of surgeons and transplant coordinators for long-term management.
South Korean cardiology centers report a 91% 1-year survival rate for heart failure. The 5-year survival rate reaches 79% through guideline-directed medical therapy. Tertiary hospitals have reduced in-hospital mortality for acute cases to 2.2%. Patients benefit from KOIHA-accredited safety standards in major cities.
Bookimed Expert Insight: Success in Korea is driven by high-volume specialized centers like Sejong Hospital. Their specialists often hold leadership roles in global cardiology committees. Dr. Oh Dong Joo has published over 240 international papers. This research-heavy environment ensures patients receive the newest medication protocols before they become global standards.
Patient Consensus: Patients emphasize that success means better breathing and fewer hospital stays rather than a cure. They note that staying consistent with weight tracking and salt intake is vital for long-term stability.
Hospitalization for acute heart failure stabilization in South Korea typically lasts 5 to 10 days. Patients return home once they achieve hemodynamic stability and fluid balance. Long-term recovery for heart function improvement generally requires 3 to 6 months of optimized medication and specialized monitoring.
Bookimed Expert Insight: South Korea offers a high density of specialized expertise for complex cases. Dr. Kyung Hee Kim at Sejong Hospital leads a multidisciplinary team focusing on advanced heart failure and mechanical support. This integrated approach at high-volume centers, which treat over 400,000 patients annually, often results in more precise medication optimization during the initial 10-day stay.
Patient Consensus: Patients note that discharge depends more on breathing improvement and kidney function than a set calendar date. They emphasize that the first weeks at home are critical for monitoring weight and swelling to prevent returning to the hospital.
Cardiac rehabilitation is a standard part of chronic heart failure treatment in South Korea. The National Health Insurance system has covered these programs since 2017. Clinical guidelines established in 2019 integrate assessment, supervised exercise therapy, and education into recovery protocols at major cardiac centers.
Bookimed Expert Insight: Coordination between acute care and recovery is exceptionally high at specialized centers. Sejong Hospital manages over 400,000 patients annually and maintains 28 distinct departments. This high volume allows for a seamless transition from advanced interventions like VAD or transplantation to structured rehabilitation. Patients should choose multispecialty hubs to ensure rehab starts immediately after stabilization.
Patient Consensus: Patients note that structured rehab programs significantly boost physical stamina and reduce anxiety after a heart event. Many advise asking your cardiologist about supervised exercise early, as it might not be automatically volunteered during routine checkups.
Patients do not need South Korean residency to receive specialized cardiac care. The Republic of Korea offers advanced cardiology services to international patients through medical visas or short-term entry. High-volume centers like Sejong Hospital provide complex heart failure and transplantation management for non-residents.
Bookimed Expert Insight: While any major hospital can technically treat non-residents, specialized clinics like Sejong Hospital manage over 400,000 patients annually. This massive volume allows their 100+ doctors to maintain high proficiency in rare heart failure interventions. Choosing a dedicated heart center over a general university hospital often streamlines the deposit and translation process for foreign nationals.
Patient Consensus: Patients note that gathering translated echo reports and lab results is the biggest hurdle. Most emphasize that specialized care is concentrated in large urban hospitals where international departments handle the complex paperwork.
South Korea integrates digital technology into heart failure care through AI-powered ECG diagnostics and remote monitoring of cardiac devices. The infrastructure supports portable Bluetooth-enabled sensors for rapid detection of arrythmias. These tools connect patients to multidisciplinary teams within JCI or KOIHA-accredited systems for proactive management.
Bookimed Expert Insight: While many search for the latest gadgets, South Korea's real strength lies in high-volume center data integration. Specialist centers like Sejong Hospital manage over 400,000 annual visits. This massive patient volume allows leaders like Prof. Dr. Byung Hee Oh to refine AI algorithms using millions of data points. This ensures diagnostic accuracy that smaller, less digitalized systems cannot easily replicate.
Patient Consensus: Patients note that technology feels most valuable when it prevents hospitalizations through simple features like automated fluid retention alerts. They emphasize that digital tools must be backed by a responsive medical team to be truly effective.
The Korean Society of Heart Failure guidelines mandate four pillars of medical therapy. These pillars are for heart failure with reduced ejection fraction. They include ARNI or ACEi/ARB agents, beta-blockers, mineralocorticoid receptor antagonists, and SGLT2 inhibitors. This quadruple therapy is used across South Korean cardiac centres. It aims to reduce cardiovascular mortality and hospitalisation.
Bookimed Expert Insight: South Korea's leading cardiologists often lead national societies. These include Dr Byung Hee Oh at Sejong Hospital. This means clinics like Sejong or Naeun Hospital implement new global guidelines rapidly. Patients benefit from an integrated approach. The quadruple therapy starts during the initial hospital stay rather than in stages.
Patient Consensus: Patients in the Republic of Korea report that doctors prioritise this. They start all four medications quickly. They emphasise bringing a full medication list. This helps the team manage blood pressure and kidney function during titration.
South Korea offers advanced mechanical support and regenerative therapies for severe heart failure. Key treatments include left ventricular assist devices (LVAD) as a bridge to transplant. Specialist centres and major hospitals also provide heart transplantation, ECMO support, and legal access to stem cell therapies for incurable cases.
Bookimed Expert Insight: While many countries restrict experimental therapies, South Korea's regenerative medicine framework allows access to cell-based treatments for severe conditions. Specialist directors like Dr Kyung Hee Kim at Sejong Hospital combine this with traditional heart transplantation expertise. This dual approach gives patients options ranging from surgical transplants to emerging biological repairs within a single healthcare system.
Patient Consensus: Patients highlight that definitive heart failure care is concentrated in large tertiary centres. They often recommend exploring stem cell options only for specific post-heart attack damage. They confirm that Korea offers efficient, technically capable specialist access.
South Korea hosts specialised heart failure clinics within major cardiovascular centres. These are mainly in Seoul and Incheon. Leading hospitals provide treatments like left ventricular assist devices (LVAD) and heart transplants. Facilities such as Sejong Hospital hold KOIHA accreditation. This accreditation means they meet rigorous international safety and quality standards.
Bookimed Expert Insight: South Korean cardiology leadership is highly concentrated. Top specialists at Incheon-based centres regularly lead national cardiovascular societies. Examples include Dr Byung Hee Oh and Dr Oh Dongju. This deep academic involvement means patients access clinical protocols. These protocols often set the national standard for chronic heart failure management.
Patient Consensus: Patients note that major university hospitals provide the most specialised care. However, appointments can feel rushed. Bringing a written symptoms list helps maximise time with specialists. This is especially useful at these large tertiary centres.
Heart failure treatment in South Korea combines guideline-directed medical therapy with structured lifestyle management. Leading cardiovascular centres, such as Sejong Hospital, employ multidisciplinary teams. These teams oversee cardiac rehabilitation and salt restriction protocols. Patients receive comprehensive discharge education to manage symptoms and reduce hospital readmissions.
Bookimed Expert Insight: Data shows South Korean cardiology leadership often bridges international standards. Specialists like Dr Kyung Hee Kim hold rare roles in the American Heart Association. This global integration means Australian patients benefit from doctors at KOIHA-accredited centres, such as Naeun Hospital. These doctors apply Western clinical rigour to high-volume preventive cardiology programs.
Patient Consensus: Patients in South Korea find managing hidden salt in prepared foods challenging. It is the most challenging lifestyle hurdle. They note that daily weight tracking and self-monitoring for shortness of breath are vital. This helps maintain stability after returning home.
Diuretics are essential for managing fluid overload and congestion in South Korean chronic heart failure patients. Following national guidelines, specialists use these agents as first-line therapy to relieve breathlessness and swelling. They do not improve survival. However, they remain indispensable for achieving stable dry body weight during intensive treatment.
Bookimed Expert Insight: South Korea’s leading cardiac centres, like Sejong Hospital, integrate diuretic management. They do so within high-volume programs serving over 400,000 patients annually. Data shows that top Korean cardiologists, including Dr Kyung Hee Kim and Dr Byung Hee Oh, often combine these symptomatic treatments with other interventions. One example is Enhanced External Counterpulsation (EECP). This approach reflects a trend. Pharmacological fluid management is paired with mechanical support to stabilise complex cases.
Patient Consensus: Patients find diuretics highly effective for quickly reducing swelling and breathlessness. However, they note that these medicines only manage symptoms. Most understand that life-extending benefits in South Korea come from a specific drug combination. This includes beta-blockers and ACE inhibitors.
Stable heart failure patients in South Korea typically visit a cardiologist every 3 to 6 months for monitoring. Initial follow-ups usually occur 1 to 2 weeks after hospital discharge. This increases to every 1 to 4 months during medication adjustments. These visits check kidney function and electrolytes.
Bookimed Expert Insight: South Korean cardiology centres offer exceptionally high specialist density. At Naeun Hospital, 90 doctors manage 27 departments. This often allows for more frequent early-stage monitoring than in Australia. Patients should note that while university hospitals have wait times, specialised heart centres provide faster titration appointments. This intensive early schedule helps stabilise patients quickly before moving to long-term 6-month cycles.
Patient Consensus: Patients find that follow-ups in South Korea start frequently, often every fortnight, but gradually space out as health improves. Many highlight that regular blood tests are essential since heart medicines can impact kidney function and potassium levels.